EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 28 / No 3 (2022) J Oral Med Oral Surg, 28 3 (2022) 36 References
Open Access
Issue
J Oral Med Oral Surg
Volume 28, Number 3, 2022
Article Number 36
Number of page(s) 8
DOI https://doi.org/10.1051/mbcb/2022017
Published online 23 September 2022
  1. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis 2020 (in press) [PubMed] [Google Scholar]
  2. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa: potentially malignant disorders. J Oral Pathol Med 2007;36:575–580. [CrossRef] [PubMed] [Google Scholar]
  3. Liu W, Wu L, Zhang Y, Shi L, Yang X. Bibliometric analysis of research trends and characteristics of oral potentially malignant disorders. Clin Oral Investig 2020;24:447–454. [CrossRef] [PubMed] [Google Scholar]
  4. Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med 2018;47:633–640. [CrossRef] [PubMed] [Google Scholar]
  5. Dziedzic A, Varoni EM. Challenges of oral medicine specialists at the time of COVID-19 pandemic. Oral Dis 2022;28:904–907. [CrossRef] [PubMed] [Google Scholar]
  6. Royal College of Surgeons of England. COVID-19. Online information available at: https://www.rcseng.ac.uk/dental-faculties/fds/coronavirus/ (accessed September 2021). [Google Scholar]
  7. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia − a systematic review and meta-analysis: Treatment and Follow-Up of Oral Dysplasia. Head Neck 2009;31:1600–1609. [CrossRef] [PubMed] [Google Scholar]
  8. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med 2016;45:155–166. [CrossRef] [PubMed] [Google Scholar]
  9. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England: Malignant transformation in OPMD. J Oral Pathol Med 2011;40:677–683. [CrossRef] [PubMed] [Google Scholar]
  10. Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck 2020;42:539–555. [CrossRef] [PubMed] [Google Scholar]
  11. Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, et al., editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017. [Google Scholar]
  12. Ho MW, Field EA, Field JK, et al. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg 2013;51:594–599. [CrossRef] [PubMed] [Google Scholar]
  13. Hankinson PM, Mohammed-Ali RI, Smith AT, Khurram SA. Malignant transformation in a cohort of patients with oral epithelial dysplasia. Br J Oral Maxillofac Surg 2021 59: 1099–1101. doi: 10.1016/j.bjoms [CrossRef] [PubMed] [Google Scholar]
  14. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement: Oral epithelial dysplasia classification systems. J Oral Pathol Med 2008;37:127–133. [CrossRef] [PubMed] [Google Scholar]
  15. Odell EW. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis. 2021;27: 1993–2007. [CrossRef] [PubMed] [Google Scholar]
  16. Alaizari NA, Sperandio M, Odell EW, Peruzzo D, Al-Maweri SA. Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders. J Oral Pathol Med 2017;47:97–103. [Google Scholar]
  17. Diniz Freitas M, Albuquerque R, Monteiro L, Fricain JC (eds). Oral Cancer Prevention. Birmingham: Clinical Photography & Design, Birmingham Dental Hospital; 2019. [Google Scholar]
  18. Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Disease. 2013;20:e19– e24. [Google Scholar]
  19. Capella DL, Gonçalves JM, Abrantes AAA, Grando LJ, Daniel FI. Proliferative verrucous leukoplakia: diagnosis, management and current advances. Braz J Otorhinolaryngol 2017;83:585–593. [CrossRef] [PubMed] [Google Scholar]
  20. Torrejon-Moya A, Jané-Salas E, López-López J. Clinical manifestations of oral proliferative verrucous leukoplakia: a systematic review. J Oral Pathol Med 2020;49:404–408. [CrossRef] [PubMed] [Google Scholar]
  21. Van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010;46:423–425. [CrossRef] [PubMed] [Google Scholar]
  22. Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians: Oral cancer and oral erythroplakia. Aust Dent J 2011;56:253–256. [CrossRef] [PubMed] [Google Scholar]
  23. Kalavrezos N, Scully C. Mouth cancer for clinicians part 6: Potentially malignant disorders. Dent Update 2015;42:866–888, 871–874, 877. [CrossRef] [PubMed] [Google Scholar]
  24. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: A study of 723 patients. J Am Acad Dermatol 2002;46:207–214. [CrossRef] [PubMed] [Google Scholar]
  25. González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol 2019;96:121–130. [CrossRef] [PubMed] [Google Scholar]
  26. Rotaru D, Chisnoiu R, Picos AM, Picos A, Chisnoiu A. Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med 2020;20:198. [PubMed] [Google Scholar]
  27. Lucchese A, Dolci A, Minervini G, et al. Vulvovaginal gingival lichen planus: report of two cases and review of literature. Oral Implantol (Rome) 2016;9:54–60. [CrossRef] [PubMed] [Google Scholar]
  28. Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev 2020;2:CD001168. [PubMed] [Google Scholar]
  29. Kaplan I, Ventura-Sharabi Y, Gal G, Calderon S, Anavi Y. The Dynamics of Oral Lichen Planus: A Retrospective Clinicopathological Study. Head and Neck Pathology 2011;6:178–183. [Google Scholar]
  30. McParland H, Warnakulasuriya S. Oral lichenoid contact lesions to mercury and dental amalgam − a review. J Biomed Biotechnol 2012;2012:589569. [CrossRef] [PubMed] [Google Scholar]
  31. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125:582–590. [CrossRef] [PubMed] [Google Scholar]
  32. Suter VGA, Warnakulasuriya S. The role of patch testing in the management of oral lichenoid reactions. J Oral Pathol Med 2016;45:48–57. [CrossRef] [PubMed] [Google Scholar]
  33. Montebugnoli L, Venturi M, Gissi DB, Cervellati F. Clinical and histologic healing of lichenoid oral lesions following amalgam removal: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:766–772. [CrossRef] [PubMed] [Google Scholar]
  34. Kerr AR, Warnakulasuriya S, Mighell AJ, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities: Oral submucous fibrosis, medical management. Oral Dis 2011;17:42–57. [Google Scholar]
  35. Kujan O, Mello FW, Warnakulasuriya S. Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Dis 2021;27:1936–1946. [CrossRef] [PubMed] [Google Scholar]
  36. Ray JG, Chatterjee R, Chaudhuri K. Oral submucous fibrosis: a global challenge. Rising incidence, risk factors, management, and research priorities. Periodontology 2000-2019;80:200–212. [CrossRef] [PubMed] [Google Scholar]
  37. Chourasia N, Borle R, Vastani A. Concomitant association of oral submucous fibrosis and oral squamous cell carcinoma and incidence of malignant transformation of oral submucous fibrosis in a population of central India: a retrospective study. J Maxillofac Oral Surg 2015;14:902–906. [CrossRef] [PubMed] [Google Scholar]
  38. Odell EW. Cawson's essentials of oral pathology and oral medicine. 9th ed. Elsevier; 2017. [Google Scholar]
  39. Arvanitidou I-E, Nikitakis NG, Georgaki M, Papadogeorgakis N, Tzioufas A, Sklavounou A. Multiple primary squamous cell carcinomas of the lower lip and tongue arising in discoid lupus erythematosus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125:e22– e30. [CrossRef] [PubMed] [Google Scholar]
  40. Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 2019;96:1–13. [CrossRef] [PubMed] [Google Scholar]
  41. Dancyger A, Heard V, Huang B, Suley C, Tang D, Ariyawardana A. Malignant transformation of actinic cheilitis: A systematic review of observational studies. J Investig Clin Dent 2018;9:e12343. [CrossRef] [PubMed] [Google Scholar]
  42. Bongiorno M, Rivard S, Hammer D, Kentosh J. Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:e239–e242. [CrossRef] [PubMed] [Google Scholar]
  43. Elad S, Zadik Y, Caton JG, Epstein JB. Oral mucosal changes associated with primary diseases in other body systems. Periodontol 2000-2019;80:28–48. [CrossRef] [PubMed] [Google Scholar]
  44. Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014;25:435–441. [CrossRef] [PubMed] [Google Scholar]
  45. Chang J, Sunwoo JB, Shah JL, Hara W, Hong J, Colevas AD, et al. Association between immunosuppression and outcomes in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg 2021;164:1044–1051. [CrossRef] [PubMed] [Google Scholar]
  46. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891–1901. [CrossRef] [PubMed] [Google Scholar]
  47. Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol 2020;102:104550. [CrossRef] [PubMed] [Google Scholar]
  48. Sankari SL, Gayathri K, Balachander N, Malathi L. Candida in potentially malignant oral disorders. J Pharm Bioallied Sci 2015;7:s162–s164. [Google Scholar]
  49. Vail M, Robinson S, Condon H. Recognition of oral potentially malignant disorders and transformation to oral cancer. JAAPA 2020;33:14–18. [CrossRef] [PubMed] [Google Scholar]
  50. Walsh T, Liu JLY, Brocklehurst P, Glenny A-M., Lingen M, Kerr AR, et al. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev 2013;CD010173. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.